Jacquelien ten Dam
Director/Board Member chez MAUNA KEA TECHNOLOGIES
Profil
Jacquelien ten Dam is an Independent Director at Mauna Kea Technologies SA and the Chief Financial Officer at Mimetas BV.
She graduated from the University of Leiden.
Postes actifs de Jacquelien ten Dam
| Sociétés | Poste | Début |
|---|---|---|
| MAUNA KEA TECHNOLOGIES | Director/Board Member | 01/01/2021 |
Mimetas BV
 Mimetas BV BiotechnologyHealth Technology Mimetas BV develops organ-on-a-chip technology for testing of new medicines in high-throughput on miniaturized organ and disease models. It develops microfluidics-based culture plates that enable culturing and screening of a range of 3D organ and tissue models. The firm offers OrganoPlates microfluidics-based culture plates that serve as early stage screening models predicting toxic side effects and drug efficacy. The company was founded by Paul Vulto and Jos Joore in 2013 and is headquartered in Leiden, the Netherlands. | Director of Finance/CFO | - |
Formation de Jacquelien ten Dam
| University of Leiden | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MAUNA KEA TECHNOLOGIES | Health Technology |
| Entreprise privées | 1 |
|---|---|
Mimetas BV
Mimetas BV BiotechnologyHealth Technology Mimetas BV develops organ-on-a-chip technology for testing of new medicines in high-throughput on miniaturized organ and disease models. It develops microfluidics-based culture plates that enable culturing and screening of a range of 3D organ and tissue models. The firm offers OrganoPlates microfluidics-based culture plates that serve as early stage screening models predicting toxic side effects and drug efficacy. The company was founded by Paul Vulto and Jos Joore in 2013 and is headquartered in Leiden, the Netherlands. | Health Technology |
